- $160.73m
- $135.71m
- $51.90m
- 96
- 20
- 62
- 62
Annual income statement for Joint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K/A | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58.7 | 80 | 101 | 47 | 51.9 |
Cost of Revenue | |||||
Gross Profit | 52.2 | 72.3 | 92.1 | 36.5 | 40.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 53.2 | 73.9 | 100 | 46.7 | 53.7 |
Operating Profit | 5.49 | 6.13 | 0.828 | 0.318 | -1.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.41 | 6.06 | 0.695 | 0.254 | -1.47 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.2 | 7.57 | 0.627 | -10.8 | -1.54 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 13.2 | 7.57 | 0.627 | -9.75 | -8.53 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.2 | 7.57 | 0.627 | -9.75 | -8.53 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.902 | 0.57 | 0.21 | -0.698 | 0.031 |